These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32073451

  • 1. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy.
    Fields JA, Swinton MK, Soontornniyomkij B, Carson A, Achim CL.
    AIDS; 2020 Jun 01; 34(7):1001-1007. PubMed ID: 32073451
    [Abstract] [Full Text] [Related]

  • 2. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
    Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H.
    BMC Neurol; 2009 Dec 22; 9():63. PubMed ID: 20028512
    [Abstract] [Full Text] [Related]

  • 3. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.
    BMC Neurol; 2015 Apr 01; 15():51. PubMed ID: 25880550
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB, Robertson K, Gray R, Wawer MJ, Sacktor N, Boulware DR.
    J Neurovirol; 2017 Jun 01; 23(3):369-375. PubMed ID: 27995575
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels.
    Slaets S, Le Bastard N, Martin JJ, Sleegers K, Van Broeckhoven C, De Deyn PP, Engelborghs S.
    J Alzheimers Dis; 2013 Jun 01; 36(4):759-67. PubMed ID: 23666174
    [Abstract] [Full Text] [Related]

  • 9. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, De Carlo C, Padiglioni C, Mastrocola S, Lisetti V, Calabresi P.
    J Alzheimers Dis; 2012 Jun 01; 29(1):229-38. PubMed ID: 22232006
    [Abstract] [Full Text] [Related]

  • 10. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
    Spallazzi M, Barocco F, Michelini G, Immovilli P, Taga A, Morelli N, Ruffini L, Caffarra P.
    Acta Neurol Belg; 2019 Sep 01; 119(3):445-452. PubMed ID: 30847669
    [Abstract] [Full Text] [Related]

  • 11. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A.
    J Alzheimers Dis; 2015 Sep 01; 45(4):1077-88. PubMed ID: 25649653
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study.
    Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.
    Alzheimers Res Ther; 2018 Aug 23; 10(1):85. PubMed ID: 30134967
    [Abstract] [Full Text] [Related]

  • 13. Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.
    Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM.
    Arch Neurol; 2011 Sep 23; 68(9):1137-44. PubMed ID: 21555603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Small Vessel Disease and Associations with Cerebrospinal Fluid Amyloid, Tau, and Neurodegeneration (ATN) Biomarkers and Cognition in Young Onset Dementia.
    Yatawara C, Ng KP, Cristine Guevarra A, Wong B, Yong T, Kandiah N.
    J Alzheimers Dis; 2020 Sep 23; 77(3):1305-1314. PubMed ID: 32925034
    [Abstract] [Full Text] [Related]

  • 16. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZ, Stella F, Machado-Vieira R, Gattaz WF.
    Bipolar Disord; 2016 Feb 23; 18(1):63-70. PubMed ID: 26876913
    [Abstract] [Full Text] [Related]

  • 17. Reduced CSF carboxyterminally truncated Abeta peptides in frontotemporal lobe degenerations.
    Bibl M, Mollenhauer B, Wolf S, Esselmann H, Lewczuk P, Kornhuber J, Wiltfang J.
    J Neural Transm (Vienna); 2007 Feb 23; 114(5):621-8. PubMed ID: 17245538
    [Abstract] [Full Text] [Related]

  • 18. Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Bridel C, Somers C, Sieben A, Rozemuller A, Niemantsverdriet E, Struyfs H, Vermeiren Y, Van Broeckhoven C, De Deyn PP, Bjerke M, Nagels G, Teunissen CE, Engelborghs S.
    Brain; 2022 Nov 21; 145(11):4056-4064. PubMed ID: 35026840
    [Abstract] [Full Text] [Related]

  • 19. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
    Somers C, Struyfs H, Goossens J, Niemantsverdriet E, Luyckx J, De Roeck N, De Roeck E, De Vil B, Cras P, Martin JJ, De Deyn PP, Bjerke M, Engelborghs S.
    J Alzheimers Dis; 2016 Aug 10; 54(1):383-95. PubMed ID: 27567807
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH, Cogo-Moreira H, Rabin JS, Black SE, Swardfager W, Alzheimer's Disease Neuroimaging Initiative.
    J Neurosci; 2019 Sep 11; 39(37):7428-7437. PubMed ID: 31350262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.